Anna Albecka
Impact in
- Hepatology top 2%
- Hepatitis C virus research
- Virology top 5%
- HIV Research and Treatment
Papers in
-
- Herpesvirus Infections and Treatments 3
- Virology and Viral Diseases 2
- Hepatitis B Virus Studies 2
- Co-authors
- Leo C. James (10 shared papers)Donna L. Mallery (7 shared papers)Andrew P. Carter (2 shared papers)David Paul (2 shared papers)Jean Dubuisson (7 shared papers)Sandrine Belouzard (4 shared papers)Laura Pellegrini (1 shared paper)Max J. Kellner (1 shared paper)
- Journals
- Journal of Virology (3 papers)Nature Communications (3 papers)Hepatology (2 papers)The EMBO Journal (1 paper)Cell stem cell (1 paper)
- Partner nations
- United KingdomFranceUnited States
In The Last Decade
Anna Albecka
23 papers receiving 1.7k citations
Anna Albecka's Hit Papers
Peers
Comparison fields: 5 of 102
- Hepatology 343
- Virology 138
- Infectious Diseases 481
- Neurology 223
- Epidemiology 434
Countries citing papers authored by Anna Albecka
This map shows the geographic impact of Anna Albecka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Albecka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Albecka more than expected).
Fields of papers citing papers by Anna Albecka
This network shows the impact of papers produced by Anna Albecka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Albecka. The network helps show where Anna Albecka may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna Albecka, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | SARS-CoV-2 Infects the Brain Choroid Plexus and Disrupts the Blood-CSF Barrier in Human Brain Organoids Hit paper breakdown → | 2020 | 394 |
| 2 | 2011 | 230 | |
| 3 | Furin cleavage of SARS-CoV-2 Spike promotes but is not essential for infection and cell-cell fusion Hit paper breakdown → | 2021 | 226 |
| 4 | 2011 | 142 | |
| 5 | 2011 | 131 | |
| 6 | 2015 | 122 | |
| 7 | 2020 | 65 | |
| 8 | 2010 | 59 | |
| 9 | 2011 | 49 | |
| 10 | 2015 | 42 | |
| 11 | 2016 | 42 | |
| 12 | 2023 | 39 | |
| 13 | 2021 | 25 | |
| 14 | 2020 | 23 | |
| 15 | 2013 | 22 | |
| 16 | 2023 | 20 | |
| 17 | 2019 | 18 | |
| 18 | 2021 | 18 | |
| 19 | 2022 | 15 | |
| 20 | 2024 | 5 |
About Anna Albecka
Anna Albecka is a scholar working on Epidemiology, Molecular Biology, Infectious Diseases, Hepatology and Immunology, having authored 23 papers that have together received 1.7k indexed citations. Recurring topics across this work include Hepatitis C virus research (6 papers), SARS-CoV-2 and COVID-19 Research (5 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), interferon and immune responses (3 papers), Herpesvirus Infections and Treatments (3 papers), HIV Research and Treatment (3 papers), Virology and Viral Diseases (2 papers) and Hepatitis B Virus Studies (2 papers). The work is most often cited by research in Hepatology (343 citations), Virology (138 citations), Infectious Diseases (481 citations), Neurology (223 citations) and Epidemiology (434 citations). Anna Albecka has collaborated with scholars based in United Kingdom, France and United States. Frequent co-authors include Leo C. James, Donna L. Mallery, Andrew P. Carter, David Paul, Jean Dubuisson, Sandrine Belouzard, Laura Pellegrini, Max J. Kellner, Madeline A. Lancaster and Véronique Descamps. Their work appears in journals such as Journal of Virology, Nature Communications, Hepatology, The EMBO Journal and Cell stem cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.